September 18, 2026

LifeMD, Inc. (LFMD) Stock Analysis: Potential Upside of 153.91% Sparks Investor Interest

LifeMD, Inc. (NASDAQ: LFMD), a burgeoning player in the healthcare sector, is carving out a niche in the rapidly expanding telehealth industry. Operating primarily in the United States, LifeMD provides..

Oculis Holding AG (OCS) Stock Analysis: Unveiling a Potential 254.75% Upside in the Biotech Space

In the ever-evolving world of biotechnology, Swiss-based Oculis Holding AG (NASDAQ: OCS) has emerged as a promising player with significant growth potential. With a market capitalization of $554.17 million, Oculis..

Immatics N.V. (IMTX) Stock Analysis: A Biotech Pioneer with Nearly 100% Upside Potential

Immatics N.V. (IMTX) is making waves in the biotechnology sector, demonstrating a commitment to pioneering therapies in the fight against cancer. With a market capitalization of $1.34 billion and a..

Cronos Group Inc. (CRON) Stock Analysis: A Closer Look at Revenue Growth Amidst Valuation Challenges

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the cannabinoid sector, has drawn significant attention from investors due to its remarkable revenue growth and strategic positioning within the healthcare..

Praxis Precision Medicines (PRAX) Stock Analysis: Evaluating a Potential 105.72% Upside in CNS Therapies

Praxis Precision Medicines, Inc. (NASDAQ: PRAX) has emerged as a notable player in the biotechnology sector, focusing on developing therapies for central nervous system (CNS) disorders. With a market capitalization..

InnovAge Holding Corp. (INNV) Stock Analysis: Exploring a 12% Upside Potential Amidst Healthcare Innovations

InnovAge Holding Corp. (NASDAQ: INNV) is catching the attention of investors with its unique approach to elder care, operating within the expansive healthcare sector. Headquartered in Denver, Colorado, InnovAge focuses..

Simulations Plus, Inc. (SLP) Stock Analysis: Navigating the Healthcare Software Space with a 7.5% Revenue Growth

Simulations Plus, Inc. (NASDAQ: SLP), a renowned player in the healthcare sector, is making waves in the health information services industry with its innovative software solutions for drug discovery and..

Neuropace, Inc. (NPCE) Stock Analysis: 43% Potential Upside with Strong Buy Ratings

Neuropace, Inc. (NASDAQ: NPCE) is capturing attention in the healthcare sector, particularly within the medical devices industry, due to its innovative approach in treating drug-resistant focal epilepsy. With a market..

Cel-Sci Corporation (CVM) Stock Analysis: Unpacking the 738% Potential Upside

In the dynamic world of biotechnology, Cel-Sci Corporation (CVM) stands out with a remarkable potential upside of nearly 739%, according to current analyst ratings. This intriguing figure is largely attributed..

Butterfly Network, Inc. (BFLY) Stock Report: Promising 34% Upside Potential in the Medical Devices Sector

Butterfly Network, Inc. (NYSE: BFLY), a pioneering company in the healthcare sector, is making waves in the medical devices industry with its innovative ultrasound imaging solutions. Headquartered in Burlington, Massachusetts,..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating a 27.74% Upside Potential in the Healthcare Sector

Phibro Animal Health Corporation (NASDAQ: PAHC), a key player in the healthcare sector, particularly in the niche of specialty and generic drug manufacturing, is capturing investor attention with a notable..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Unpacking a Potential 41% Upside in the Biotech Sector

Relay Therapeutics, Inc. (NASDAQ: RLAY) is making waves in the biotechnology sector with its pioneering approach to precision medicine. Headquartered in Cambridge, Massachusetts, Relay Therapeutics focuses on the discovery and..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating Challenges in the Healthcare Staffing Sector

Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands as a pivotal player in the healthcare staffing sector, providing essential talent management services across the United States. With a market capitalization of..

SIGA Technologies Inc. (SIGA) Stock Analysis: Evaluating the Prospects Amid a Challenging Landscape

For investors keeping an eye on the healthcare sector, SIGA Technologies Inc. (NASDAQ: SIGA) presents a compelling case for analysis. Known for its focus on the health security market, SIGA’s..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Robust Revenue Growth and Analyst Optimism Signal Potential Upside

Sonida Senior Living, Inc. (SNDA), a notable player in the healthcare sector specializing in medical care facilities, presents a compelling opportunity for investors with its impressive revenue growth and bullish..

Fulgent Genetics, Inc. (FLGT) Investor Outlook: Navigating a Complex Landscape in the Diagnostics Sector

Fulgent Genetics, Inc. (NASDAQ: FLGT) presents a fascinating case for investors seeking exposure to the healthcare sector, specifically within the Diagnostics & Research industry. With a market capitalization of $601.21..

Kura Oncology, Inc. (KURA) Stock Analysis: A Biotech Innovator with a 173% Potential Upside

Kura Oncology, Inc. (NASDAQ: KURA) is making waves in the biotechnology sector with its innovative approach to cancer treatment. Based in San Diego, California, this clinical-stage biopharmaceutical company is dedicated..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Potential Upside of Over 57% Ignites Investor Interest

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) is making waves in the biotechnology sector, attracting attention with its promising pipeline and a substantial potential upside. With a market capitalization of $1.37 billion,..

GH Research PLC (GHRS): Investor Outlook on a Biotech Stock with a 49% Potential Upside

GH Research PLC (NASDAQ: GHRS), a clinical-stage biopharmaceutical company headquartered in Dublin, Ireland, is capturing the attention of investors with its innovative approach to treating depression. Specializing in the healthcare..

uniQure N.V. (QURE) Stock Analysis: A Biotech Powerhouse with a 56% Upside Potential

uniQure N.V. (QURE), a prominent player in the biotechnology sector, is catching the attention of investors with its robust portfolio of gene therapy candidates and a promising potential upside. Based..

Search

Funds

September 18, 2026

Search

Funds

September 18, 2026

FTSE 100

Funds